摘要:19详见(《重庆华邦制药股份有限公司2007年第三季度季度报告》)。......
汇兑收益(损失以“-”号填列)
|
|
|
|
|
三、营业利润(亏损以“-”号填列)
| 64,098,265.34
| 37,307,747.49
| 32,542,331.89
| 30,526,159.92
|
加:营业外收入
| 3,894.50
|
|
|
|
减:营业外支出
| -134,610.61
|
| 8,661.50
| 5,811.50
|
其中:非流动资产处置损失
| -134,610.61
|
|
|
|
四、利润总额(亏损总额以“-”号填列)
| 64,236,770.45
| 37,307,747.49
| 32,533,670.39
| 30,520,348.42
|
减:所得税费用
| 8,197,995.23
| 4,715,756.19
| 5,292,444.91
| 4,897,464.30
|
五、净利润(净亏损以“-”号填列)
| 56,038,775.22
| 32,591,991.30
| 27,241,225.48
| 25,622,884.12
|
归属于母公司所有者的净利润
关键字:
|